The Consumer Justice Foundation Alerts Public to Washington University in St. Louis Study Concerning Use of Depakote by Children with Bipolar Disorder

Share Article

The Consumer Justice Foundation, a for-profit corporation whose Web site can be found at the URL of http://www.depakotebirthinjury.com and which is staffed by professional consumer advocates who provide free online educational resource to the public regarding the potential dangers of prescription medication, hereby alert the public to a recent study concerning Depakote. The study was performed by researchers at Washington University in St. Louis and it concluded that Depakote performed the worst of the three drugs involved in the study involving children with bipolar disorder.

The Consumer Justice Foundation, a for-profit corporation whose staff of professional consumer advocates provide free online educational resources to the public regarding the potential dangers of using certain prescription medications, hereby alert the public of a recent study performed that reviewed the effectiveness of Depakote when compared to other common medications prescribed to treat bipolar disorder in children.

Specifically, this study, which was performed by researchers at Washington University in St. Louis and that was published in the January 2012 issue of Archives of General Psychiatry, reviewed the progress of 290 children who took part in the study for up to eight weeks. The children subjects were broken down into three groups, and each was given a certain medication: one group was given lithium, one was given risperidone, which is commonly referred to as Risperdal and one group was given divalproex sodium, which is commonly known as Depakote to measure the progress regarding their manic episodes.

Over the course of the eight-week study that was led by BarbaraGeller, M.D., 68.5 percent of the children taking risperidone showed improvements in their manic symptoms, compared with only 35.6 percent of the children taking lithium and 24 percent of those taking divalproexsodium. In addition, some of the subjects experienced Depakote side effects that included weight gain that averaged 3.7 pounds. Throughout the study, 26 percent of the children taking Depakote discontinued their participation.

This study was funded by the National Institute of Mental Health and was designed to provide an analysis of which prescription medications that were commonly prescribed would generally perform the best for children who were between the ages of 6 and 15 years old. The study concluded that those using Risperdal showed the most improvement with their symptoms.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site is located at http://www.consumerjusticefoundation.com, is a public resource that's been built and maintained by a group of concerned professionals who want to provide general information for consumers regarding the potential dangers involved with the use of Depakote while pregnant. This resource is not to be considered as medical or legal advice, which should only be dispensed by a licensed medical doctor or a Depakote lawyer.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website